# Possibility of screening for mild cognitive impairment via an eye tracking-based cognitive scale

## TL;DR

This study explores using eye tracking and virtual reality to screen for mild cognitive impairment, showing it is as effective as traditional tests.

## Contribution

The study introduces a VR-based eye tracking tool for MCI screening with comparable accuracy to established methods like MoCA.

## Key findings

- VR-E showed significant differences in cognitive domains between AD, MCI, and healthy control groups.
- VR-E had an area under the curve of 0.857 for MCI vs. healthy controls and 0.870 for MCI vs. AD.
- VR-E scores correlated moderately with MoCA-J and MMSE scores.

## Abstract

The Montreal Cognitive Assessment (MoCA) is widely used as a screening test for mild cognitive impairment (MCI). However, the MoCA takes approximately 15 min to administer and evaluate by skilled examiners, such as medical professionals. This study assessed whether an eye tracking-based cognitive scale using virtual reality (VR) was accurate and efficient to screen for MCI.

This study included 143 patients. The Virtual Reality-Based Cognitive Function Examination (VR-E) was used with all participants to evaluate their memory, judgment, spatial cognition, calculation, and language function.

Significant differences were observed in all cognitive domains of memory, judgment, spatial cognition, calculation, and language function between the Alzheimer’s disease (AD), MCI, and older healthy control (HC) groups. The area under the curve value of the VR-E score for the HC and MCI groups was 0.857, and that for the AD and MCI groups was 0.870. The correlation coefficient between the MMSE and VR-E scores was 0.566 (p < 0.001), and that between the Japanese version of the MoCA (MoCA-J) and VR-E scores was 0.648 (p < 0.001), which indicated a moderate correlation in both comparisons.

The VR-E had the same diagnostic performance results as the MoCA-J, thus the VR-E has potential for use in screening patients for MCI.